A proof-of-concept study promises the speedy diagnosis of lower respiratory tract infections through analysis of human breath. The work is published in PNAS Nexus.
The Peak Bio pipeline includes an antibody-drug-conjugate (ADC) platform that includes novel toxins and linkers coupled with important cancer antibody targets and a Phase 2-ready neutrophil elastase ...